Sodium Lowering and Urinary Protein Reduction Trial

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 151 participants.

Also called NCT02945969

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 151 participants (enrolled count) (from the registry)
Sponsor
Tulane University School of Public Health and Tropical Medicine (from the registry)
Registry
  • NCT NCT02945969
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02945969. Randomized; no masking; primary purpose prevention. Start 2016-11 (registry gives no type); primary completion 2021-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sodium Lowering and Urinary Protein Reduction Trial
Acronym
SUPER
Condition
Albuminuria
Intervention (Behavioral)
Low Sodium Diet
Lead sponsor
Tulane University School of Public Health and Tropical Medicine (class: other)

Record details

Record id
cardio:ct-nct02945969
Content hash
5d75ca29f23381a16776436e994542098979158e70f965183962eb43a09e6e80